Page last updated: 2024-10-31

nabumetone and Arthritis, Psoriatic

nabumetone has been researched along with Arthritis, Psoriatic in 1 studies

Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.

Arthritis, Psoriatic: A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cron, RQ1
Finkel, TH1

Other Studies

1 other study available for nabumetone and Arthritis, Psoriatic

ArticleYear
Nabumetone induced pseudoporphyria in childhood.
    The Journal of rheumatology, 2000, Volume: 27, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Butanones; Child; Female; Humans; Nab

2000